Radiation-induced leukemia among children aged 0-5 years at the time of the Chernobyl accident

被引:32
作者
Noshchenko, Andriy G. [1 ]
Bondar, Oleksandra Y. [1 ]
Drozdova, Vira D. [2 ]
机构
[1] Natl Univ Kiev Mohyla Acad, Dept Environm Sci, Kiev, Ukraine
[2] Ukraine Acad Med Sci, Inst Hematol & Blood Transfusiol, Kiev, Ukraine
关键词
leukemia; radiation; Chernobyl; Ukraine; case-control study; ATOMIC-BOMB SURVIVORS; CHILDHOOD LEUKEMIA; RADIOACTIVE FALLOUT; INTERNAL EXPOSURE; CANCER INCIDENCE; INFANT LEUKEMIA; THYROID-CANCER; RISK-FACTOR; UKRAINE; POPULATION;
D O I
10.1002/ijc.24834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This case-control study was conducted to estimate the radiation-induced risk of acute leukemia during the period from 1987 to 1997 among residents 0-5 years of age at the time of the Chernobyl accident in the most radioactively contaminated territories of the Ukraine (Rivno, Zhytomyr, Chernihiv and Cherkasy regions). Data were collected from 246 leukemia cases diagnosed between 1 January, 1987, and 31 December, 1997. Each case was verified and interviewed. Verified cases were compared to 492 randomly selected controls matched by age, sex, type of settlement (rural, semirural and urban) and administrative region of residency. The cumulative level of radiation exposure from the time of the Chernobyl accident to the date of diagnosis was assessed for each case and corresponding controls. Four dose-range groups were selected for statistical analysis (0-2.9, 3-9.9, 10-99.9 and 100-313.3 mGy). The risk of leukemia was significantly increased (-2.4 [95%CI: 1.4-4.0]) among those with radiation exposure doses higher than 10 mGy (p = 0.01). The association between radiation exposure and risk was stronger among males (-2.8 [95%CI: 1.4-5.5, p = 0.01]), and for cases of acute leukemia that were diagnosed during the period from 1987 to 1992 (-2.5 [95%CI: 1.2-5.1, p = 0.05]), particularly acute myeloid leukemia (-5.8 [95%CI: 1.4-24.6, p = 0.05]). The influence of possible confounders and methods of selecting controls on the leukemia risk assessment was analyzed. The evaluated risk per unit dose is discussed.
引用
收藏
页码:412 / 426
页数:15
相关论文
共 49 条
  • [1] [Anonymous], STAT METHODS CANC RE, DOI DOI 10.1097/00002030-199912240-00009
  • [2] BALONOV M, 1996, P 1 INT C MINSK BEL, P235
  • [3] Bebeshko VG, 1997, INT C SEV SPAIN 17 2, P337
  • [4] Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident
    Cardis, Elisabeth
    Krewski, Daniel
    Boniol, Mathieu
    Drozdovitch, Vladimir
    Darby, Sarah C.
    Gilbert, Ethel S.
    Akiba, Suminori
    Benichou, Jacques
    Ferlay, Jacques
    Gandini, Sara
    Hill, Catherine
    Howe, Geoffrey
    Kesminiene, Ausrele
    Moser, Mirjana
    Sanchez, Marie
    Storm, Hans
    Voisin, Laurent
    Boyle, Peter
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (06) : 1224 - 1235
  • [5] Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers
    Chuang, Shu-Chun
    Hashibe, Mia
    Yu, Guo-Pei
    Le, Anh D.
    Cao, Wei
    Hurwitz, Eric L.
    Rao, Jian-Yu
    Neugut, Alfred I.
    Zhang, Zuo-Feng
    [J]. CANCER LETTERS, 2006, 238 (01) : 42 - 52
  • [6] Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl power station accident:: results from an international collaborative population-based case-control study
    Davis, S
    Day, RW
    Kopecky, KJ
    Mahoney, MC
    McCarthy, PL
    Michalek, AM
    Moysich, KB
    Onstad, LE
    Stepanenko, VF
    Voillequé, PG
    Chegerova, T
    Falkner, K
    Kulikov, S
    Maslova, E
    Ostapenko, V
    Rivkind, N
    Shevchuk, V
    Tsyb, AF
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (02) : 386 - 396
  • [7] Drozdova VD, 1996, EXP ONCOL, V18, P128
  • [8] Glantz S. A., 2002, Primer of Biostatistics
  • [9] Radiotherapy for oral cancer as a risk factor for second primary cancers
    Hashibe, M
    Ritz, B
    Le, AD
    Li, G
    Sankaranarayanan, R
    Zhang, ZF
    [J]. CANCER LETTERS, 2005, 220 (02) : 185 - 195
  • [10] Hennekens C.H., 1987, EPIDEMIOLOGY MED